Quality of life in women undergoing chemotherapy for breast cancer at cancer disease hospital

Breast Cancer is a major Public Health problem because of its high incidence and mortality. It is feared by women due to negative stigma brought by its diagnosis and its psychological effects, which affect the perception of sexuality and their own personal image.The aim of the study was to evaluate the quality of life in Women undergoing chemotherapy for Breast Cancer at Cancer Disease Hospital in Lusaka, Zambia. A cross-sectional study was carried out in a specialized unit of Cancer Disease Hospital in Lusaka with a convenience sample of 50 women with breast cancer, who were undergoing chemotherapy. Participants included those aged ≥18 years, diagnosed with breast cancer at any stage of disease, being on chemotherapy from the second cycle. Data was collected using a patient demographic form and a modified and standardisation Quality of Life Questionnaire for Breast Cancer − 23 (QLQBR23) was translated and validated for use in Nyanja and Bemba. Results showed that emotional function was the most affected. In addition, the treatment affected neurocognitive functions like working memory, reaction time and organisation skills loss (mean = 22.9). The symptoms with the highest scores were insomnia (13.5), fatigue (12.4.) and loss of appetite (11.6). According to the Quality of Life Questionnaire− Breast Cancer 23, the mean score for Side effects was 17.3, meaning that many women experience side effects of chemotherapy, and impaired sexual satisfaction